BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dijk PRV, Logtenberg SJ, Groenier KH, Haveman JW, Kleefstra N, Bilo HJ. Complications of continuous intraperitoneal insulin infusion with an implantable pump. World J Diabetes 2012; 3(8): 142-148 [PMID: 22912916 DOI: 10.4239/wjd.v3.i8.142]
URL: https://www.wjgnet.com/1948-9358/full/v3/i8/142.htm
Number Citing Articles
1
Justin M. Gregory, Alan D. Cherrington, Daniel J. Moore. The Peripheral Peril: Injected Insulin Induces Insulin Insensitivity in Type 1 Diabetes. Diabetes 2020; 69(5) doi: 10.2337/dbi19-0026
2
Marga Giménez, Sanjay Purkayajtha, Vanessa Moscardó, Ignacio Conget, Nick Oliver. Intraperitoneal insulin therapy in patients with type 1 diabetes. Does it fit into the current therapeutic arsenal?. Endocrinología, Diabetes y Nutrición 2018; 65(3) doi: 10.1016/j.endinu.2018.01.001
3
Nick Oliver, Bernhard Gehr, Rayhan Lal, Peter R. van Dijk, Eric Renard. Continuous Intraperitoneal Insulin Infusion for People With Type 1 Diabetes: A Literature Review and International Position Statement. Diabetes, Obesity and Metabolism 2026; 28(10) doi: 10.1111/dom.71054
4
Hyunjoo J. Lee, Nakwon Choi, Eui-Sung Yoon, Il-Joo Cho. MEMS devices for drug delivery. Advanced Drug Delivery Reviews 2018; 128 doi: 10.1016/j.addr.2017.11.003
5
Jia He, Eric Renard, Peter Lord, Don Cohen, Bing Gu, Xiaoyi Wang, Gowtham Yenduri, Diane J. Burgess. Strategies for extended lifetime of implantable intraperitoneal insulin catheters. Journal of Controlled Release 2022; 341 doi: 10.1016/j.jconrel.2021.11.038
6
Melanie R. Nilsson. Insulin amyloid at injection sites of patients with diabetes. Amyloid 2016; 23(3) doi: 10.1080/13506129.2016.1179183
7
Emily L. DeWolf, Bernice Webber, Matthew J. Webber. Molecular engineering of designer diabetes therapeutics. Journal of Controlled Release 2026; 392 doi: 10.1016/j.jconrel.2026.114705
8
Hayley Fried. Advances in Diabetes Technology. Contemporary Endocrinology 2024;  doi: 10.1007/978-3-031-75352-7_2
9
P.R. van Dijk, S.J.J. Logtenberg, R.O.B. Gans, H.J.G. Bilo, N. Kleefstra. Intraperitoneal insulin infusion: treatment option for type 1 diabetes resulting in beneficial endocrine effects beyond glycaemia. Clinical Endocrinology 2014; 81(4) doi: 10.1111/cen.12546
10
Mohammad Fakhroleslam, Ramin Bozorgmehry Boozarjomehry. A multi‐objective optimal insulin bolus advisor for type 1 diabetes based on personalized model and daily diet. Asia-Pacific Journal of Chemical Engineering 2021; 16(4) doi: 10.1002/apj.2651
11
Jordan Magisson, Aladin Sassi, Aram Kobalyan, Charles-Thibault Burcez, Richard Bouaoun, Michel Vix, Nathalie Jeandidier, Severine Sigrist. A fully implantable device for diffuse insulin delivery at extraperitoneal site for physiological treatment of type 1 diabetes. Journal of Controlled Release 2020; 320 doi: 10.1016/j.jconrel.2020.01.055
12
Maggie J. Malone-Povolny, Taron M. Bradshaw, Elizabeth P. Merricks, C. Tyler Long, Timothy C. Nichols, Mark H. Schoenfisch. Combination of Nitric Oxide Release and Surface Texture for Mitigating the Foreign Body Response. ACS Biomaterials Science & Engineering 2021; 7(6) doi: 10.1021/acsbiomaterials.1c00022
13
Swarnali Paul, Shahnaz Begum, Hasan Parvej, Ramkrishna Dalui, Subrata Sardar, Falguni Mondal, Nayim Sepay, Umesh Chandra Halder. In vitro retardation and modulation of human insulin amyloid fibrillation by Fe3+ and Cu2+ ions. New Journal of Chemistry 2024; 48(7) doi: 10.1039/D3NJ04431A
14
Siang Ing Lee, Parth Narendran. Intraperitoneal insulin therapy for a patient with type 1 diabetes with insulin injection site inflammation. BMJ Case Reports 2014; 2014 doi: 10.1136/bcr-2014-205278
15
Erika Pedone, Amelia Caretto, Giulio Belfiori, Anna Zanardini, Sergio Di Molfetta, Luigi Laviola, Francesco Giorgino, Lorenzo Piemonti, Marina Scavini, Andrea Laurenzi. Continuous intraperitoneal insulin infusion as a valuable approach in patients with unstable type 1 diabetes: two case reports and a mini review of the literature. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1657069
16
Marga Giménez, Sanjay Purkayajtha, Vanessa Moscardó, Ignacio Conget, Nick Oliver. Intraperitoneal insulin therapy in patients with type 1 diabetes. Does it fit into the current therapeutic arsenal?. Endocrinología, Diabetes y Nutrición (English ed.) 2018; 65(3) doi: 10.1016/j.endien.2018.03.007
17
William V. Tamborlane, Miladys M. Palau‐Collazo. International Textbook of Diabetes Mellitus. 2015;  doi: 10.1002/9781118387658.ch51
18
Murugan Prasathkumar, Robert Becky, Salim Anisha, Chenthamara Dhrisya, Subramaniam Sadhasivam. Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches. Biotechnology Letters 2022; 44(2) doi: 10.1007/s10529-022-03232-3
19
Rosa Garcia-Verdugo, Michael Erbach, Oliver Schnell. A New Optimized Percutaneous Access System for CIPII. Journal of Diabetes Science and Technology 2017; 11(4) doi: 10.1177/1932296817694913
20
Keith R. Hildebrand. Drug‐Device Combinations For Chronic Diseases. 2015;  doi: 10.1002/9781119002956.ch07
21
K. T. D. Yeung, M. Reddy, S. Purkayastha. Surgical options for glycaemic control in Type 1 diabetes. Diabetic Medicine 2019; 36(4) doi: 10.1111/dme.13885
22
23
Vladimir Aleksandrovich Karpel'ev, Elena Anatol'evna Fedorova, Yury Ivanovich Philippov, Aleksandr Yur'evich Mayorov, Marina Vladimirovna Shestakova. Intraperitoneal insulin infusion: on the way to the artificial pancreas. Diabetes mellitus 2015; 18(3) doi: 10.14341/DM2015332-45
24
Lia Bally, Hood Thabit, Roman Hovorka. Finding the right route for insulin delivery – an overview of implantable pump therapy. Expert Opinion on Drug Delivery 2017; 14(9) doi: 10.1080/17425247.2017.1267138
25
E. Zini, I. Padrutt, K. Macha, A. Riederer, M. Pesaresi, T.A. Lutz, C.E. Reusch. Use of an implantable pump for controlled subcutaneous insulin delivery in healthy cats. The Veterinary Journal 2017; 219 doi: 10.1016/j.tvjl.2016.12.006